Expansion of seasonal influenza vaccination in the Americas

• Published in: BMC public health Vol. 9; no. 1; p. 361
• Main Authors: Ropero-Alvarez, Alba María, Kurtis, Hannah J, Danovaro-Holliday, M Carolina, Ruiz-Matus, Cuauhtémoc, Andrus, Jon K
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 24.09.2009; BioMed Central; BMC
• Subjects: Adult; Age Distribution; Aged; Aged, 80 and over; Americas - epidemiology; Distribution; Dosage and administration; Evidence-Based Medicine; Humans; Influenza; Influenza vaccines; Influenza Vaccines - immunology; Influenza, Human - epidemiology; Influenza, Human - prevention & control; Middle Aged; Pan American Health Organization; Population Surveillance; Prevention; Seasonal variations (Diseases); Seasons; Sentinel health events; Surveys; Vaccination; Viral Vaccines - supply & distribution; Viral Vaccines - therapeutic use; Vulnerable Populations; Young Adult; Americas; United States
• ISSN: 1471-2458; 1471-2458
• DOI: 10.1186/1471-2458-9-361

Seasonal influenza is a viral disease whose annual epidemics are estimated to cause three to five million cases of severe illness and 250,000 to 500,000 deaths worldwide. Vaccination is the main strategy for primary prevention. To assess the status of influenza vaccination in the Americas, influenza vaccination data reported to the Pan American Health Organization (PAHO) through 2008 were analyzed. Thirty-five countries and territories administered influenza vaccine in their public health sector, compared to 13 countries in 2004. Targeted risk groups varied. Sixteen countries reported coverage among older adults, ranging from 21% to 100%; coverage data were not available for most countries and targeted populations. Some tropical countries used the Northern Hemisphere vaccine formulation and others used the Southern Hemisphere vaccine formulation. In 2008, approximately 166.3 million doses of seasonal influenza vaccine were purchased in the Americas; 30 of 35 countries procured their vaccine through PAHO's Revolving Fund. Since 2004 there has been rapid uptake of seasonal influenza vaccine in the Americas. Challenges to fully implement influenza vaccination remain, including difficulties measuring coverage rates, variable vaccine uptake, and limited surveillance and effectiveness data to guide decisions regarding vaccine formulation and timing, especially in tropical countries.